-
公开(公告)号：EP4456905A1
公开(公告)日：2024-11-06
申请号：EP22844182.0
申请日：2022-12-26
申请人： MRM Health NV , Universiteit Gent
发明人： VAN DE WIELE, Tom , PINHEIRO, Iris , POSSEMIERS, Sam , BOLCA, Selin , LOPES, Joana , PANDA, Suchita
IPC分类号： A61K35/741 , A61K35/747 , A61P1/16
-
公开(公告)号：EP4452287A2
公开(公告)日：2024-10-30
申请号：EP22854429.2
申请日：2022-12-21
申请人： Solarea Bio, Inc.
发明人： SCHOTT, Eric Michael , TOLEDO, Gerardo V. , SOTO-GIRON, Maria Juliana , BALLOK, Alicia Eve , GREEN, Ryan , CHARBONNEAU, Mark
IPC分类号： A61K35/74 , A61K35/741 , A61K35/744 , A61K35/747 , A61K36/06 , A61P37/00 , A61P37/08
-
公开(公告)号：EP4009995B1
公开(公告)日：2024-10-16
申请号：EP20765075.5
申请日：2020-08-06
发明人： CAMMAROTA, Giovanni , MASUCCI, Luca
IPC分类号： A61K35/744 , A61K35/745 , A61K35/747 , A61K35/742 , A61K35/741 , A61P1/00 , A23L33/135
-
公开(公告)号：EP4442821A1
公开(公告)日：2024-10-09
申请号：EP23461550.8
申请日：2023-04-05
IPC分类号： C12N11/04 , A61K35/747 , C10B53/00
CPC分类号： C12N11/04 , C12R2001/2320210501 , A61K35/747
摘要： The subject matter of the present invention is a method of immobilizing Lactobacillus acidophilus bacteria on a biocarbon bed, characterized in that it includes steps in which biocarbon is produced; Lactobacillus acidophilus cells are brought to a logarithmic growth phase; biocarbon is mixed with Lactobacillus acidophilus cells. The subject matter of the invention is also the biocarbon with immobilized Lactobacillus acidophilus bacteria obtained by this method, for use as a dietary supplement containing active microorganism forms, preferably to be administered in the form of capsules.
-
公开(公告)号：EP3718418B1
公开(公告)日：2024-10-09
申请号：EP20169772.9
申请日：2015-08-06
IPC分类号： A23L33/15 , A23L33/10 , A23C9/20 , A61K31/525 , A61K31/7004 , A61K35/744 , A61K35/745 , A61K35/747 , A61P3/10
CPC分类号： A61K31/525 , A61K35/744 , A61K35/745 , A61K35/747 , A23V2200/320420130101 , A23V2200/32820130101 , A23V2250/64120130101 , A23V2250/704420130101 , A23L33/105 , A23L33/135 , A23L33/15 , A61K31/4415 , A61K31/593 , A61K31/7004 , A61K31/714 , A23V2002/0020130101 , A61P15/00 , A61P3/10
-
6.发明公开
公开(公告)号：EP4438050A1
公开(公告)日：2024-10-02
申请号：EP23382314.5
申请日：2023-03-31
申请人： Igen Biolab Group AG
发明人： MOSCOSO DEL PRADO UCELAY, Juan , PEREZAGUA MARIN, Carmen , USAN GRACIA, Luis ALberto , GUARDIA ALBA, María Jesús
IPC分类号： A61K35/74 , A23L33/135 , A61K9/00 , A61K35/742 , A61K35/745 , A61K35/747 , A61P35/00
CPC分类号： A61K35/74 , A61K35/742 , A61K35/745 , A61K35/747 , A61P35/00 , A23L33/135 , A61K9/0095 , A61K9/146
摘要： The present invention discloses a postbiotic composition for oral administration for use in the treatment of solid tumors in a patient, said composition comprising lysates of probiotic microorganisms of the genera Bacillus; Bifidobacterium; Lactobacillus, Saccharomyces, Streptococcus.
-
公开(公告)号：EP4436589A1
公开(公告)日：2024-10-02
申请号：EP23707799.5
申请日：2023-02-03
申请人： SYNBALANCE SRL
IPC分类号： A61K35/745 , A61K35/747 , A61P11/06 , A61K35/00
CPC分类号： A61K35/745 , A61K35/747 , A61P11/06 , A61K2035/11520130101
-
公开(公告)号：EP4426442A1
公开(公告)日：2024-09-11
申请号：EP22802230.7
申请日：2022-11-02
申请人： IIAA Limited
发明人： PERRETTA, Lorraine , NAUDE, Paul , MEYER, Tanya
IPC分类号： A61Q19/00 , A61Q5/00 , A61K8/99 , A61K35/744 , A61K35/745 , A61K35/747 , A23L33/135
CPC分类号： A61Q19/00 , A61Q5/00 , A61K8/99 , A61K2800/9220130101 , A61K35/744 , A61K35/745 , A61K35/747 , A23L33/135 , A61K9/0053 , A61K9/4875
-
公开(公告)号：EP4412630A1
公开(公告)日：2024-08-14
申请号：EP22801355.3
申请日：2022-10-04
IPC分类号： A61K35/747 , A61P25/00 , A61P25/02 , A61P25/28
CPC分类号： A61K35/747 , A61P25/00 , A61P25/02 , A61P25/28
-
公开(公告)号：EP4410953A1
公开(公告)日：2024-08-07
申请号：EP22876959.2
申请日：2022-09-30
发明人： KIM, Dong-Hyun
IPC分类号： C12N1/20 , A61K35/747 , A61K35/745 , A61K35/744 , A23L33/135
CPC分类号： A23L33/135 , A61K35/744 , A61K35/745 , A61K35/747 , A61P25/28 , A61P29/00 , C12N1/20 , C12R2001/0120210501 , C12R2001/22520210501 , C12R2001/4620210501
摘要： The present invention relates to Lactobacillus rhamnosus, Bifidobacterium longum, and Lactococcus lactis, which are novel lactic acid bacteria. The strains according to the present invention have high utility as a medicine or food and, in particular, can be used for preventing, treating, or relieving inflammatory diseases and neurological diseases, due to having an excellent antioxidant effect, inflammation-relieving effect, nerve-improving effect, cognition-improving effect, intestinal microbiota imbalance-improving effect, etc. In addition, the present invention can be used for regulating and enhancing immunity by increasing the activity of the immune system through immune function-improving and immunity-enhancing effects.
-
-
-
-
-
-
-
-
-
搜索结果
864 条记录 (耗时 0.02 秒)
